The Impact of Tyrosine Kinase Inhibitors (TKI) on Philadelphia positive Acute Lymphoblastic Leukemia (Ph+ ALL) following Reduced Intensity Conditioning (RIC)and Myeloablative Conditioning (MA) Allogeneic Stem Cell Transplantation(HCT)
|Effective start/end date||1/1/11 → 12/31/13|
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.